A
dramatic
increase
incidence
HPV-related
oropharyngeal
cancer
reported
parts
western
world
past
30
years
.

They
constitute
clinically
distinct
subgroup
cancers
terms
molecular
biology
,
patient
characteristics
,
treatment
outcome
.

This
chapter
describes
molecular
characteristics
,
epidemiology
,
demographics
HPV-related
head
neck
cancers
discuss
available
methods
detect
HPV-related
tumours
.

The
impact
HPV-related
biomarkers
clinical
studies
radiotherapy
,
altered
fractionation
,
modulation
hypoxia
,
concurrent
chemo-
bio-radiotherapy
reviewed
well
perspectives
de-escalation
immune-modulation
discussed
.

